Anise, aTTP patient, US

Anise, aTTP patient, US

Anise, aTTP patient, US

Patient Advocacy at Sanofi in the U.S.

We engage with advocacy groups from early research throughout the lifecycle of Sanofi medicines and vaccines.

Patients and Science are at the Center of Everything We Do at Sanofi

This is reflected in our relationships and work with U.S. patient advocacy groups. Sanofi recognizes and respects the vital and tireless work that patient advocacy groups perform every day on behalf of the patients and families they serve. We engage with the patient advocacy community to listen to their perspectives, understand what matters most to patients, and champion these patient-centric insights internally and externally.

Partnering on Shared Goals Focused on the Needs of Patients

We engage with patient advocacy groups from early research throughout the lifecycle of Sanofi medicines and vaccines. Partnerships work to achieve shared goals with the U.S. patient advocacy community that are focused on patients:

Advance Innovation

Engage patients to accelerate research and development of breakthrough medicines and vaccines

Facilitate Access

Improve appropriate patient access and affordability

Improve Health

Empower patients to have informed discussions with their providers and improve their health

Principles That Define Our Approach with Patient Advocacy Groups

How we partner is driven by:

  • Truly listening
  • Open, honest dialogue
  • Mutual respect
  • Collaboration and partnerships
  • Transparency
  • Highest standard of ethics and integrity

At a Glance: Working with the Advocacy Community

2023 Torch Awards

The Sanofi U.S. Public Affairs & Patient Advocacy Team aspires to be the partner of the U.S. patient advocacy community that improves patient access to medicines and vaccines that can potentially transform lives and change the practice of medicine. We want to be a partner who listens, acts and leads.
Eric Racine

Eric Racine

Vice President & Head, US Public Affairs & Patient Advocacy

Edna, living with nasal polyps, US
Edna, living with nasal polyps, US

Sponsorships and Contributions

Sanofi supports specific activities and initiatives of U.S. patient advocacy groups that are focused on improving patient care. Sponsorship requests are submitted through applications completed on our online portals to be evaluated by an internal committee.

Geoff, Multiple Sclerosis, US
Geoff, Multiple Sclerosis, US

Patient-Centered Healthcare Value Assessment

We have a commitment to promoting healthcare systems that make our treatments accessible and affordable to patients in need. We encourage a transition to value-driven healthcare—when access is aligned with the highest-quality care—while enabling us to continue to advance scientific knowledge and bring innovative treatments to patients worldwide.

 Princeton, Pompe patient, US
Princeton, Pompe patient, US

Health Equity at Sanofi in the U.S.

We believe every person should have the opportunity to be as healthy as possible, and no one should be disadvantaged from getting the care they deserve.

Our goal is to accelerate health equity so all patients have access to transformative medicines and vaccines.

Community of Practice and Patient Advocacy Voices Podcast

Problems facing patients today are too big for any one organization to solve. This is why Sanofi formed a Community of Practice in 2023 for patient advocacy groups to connect, share pragmatic insights, and learn from each other to accelerate their impact for patients.  This community has grown to more than 90 organizations and 250 individuals who participate in quarterly webinars. In 2024, topics will include Generative AI, Measuring Program Impact, and Data. 

Please see reports from our past CoP webinars on building trust in underserved communities and practical ways to utilize Artificial Intelligence below.

If you are interested in joining the Advocacy Community of Practice (CoP), click "Join the COP" below to get connected.

Sanofi podcast, Patient Advocacy Voices, highlights unsung heroes from advocacy groups who work tirelessly for the well-being of patients and their families. Subscribe here: Patient Advocacy Voices

Join the CoP

Click the button below to join a community of advocacy leaders in a variety of disease states, locations, and experiences. Together, they are dedicated to sharing actionable best practices with each other to accelerate each organization's impact on health equity.

CoP Kickoff Summary - What to Expect

The first convening of the community of practice established its vision and cadence. This report details the community's purpose, value, topics of learning, and concrete next steps.

Forum on Gaining Trust Through Local Partnerships and Programs

Patient advocacy leaders shared insights about successful approaches their organizations are using to build trust with their patient communities. This report summarizes key takeaways from CoP participants as well as useful resources to help US advocacy groups implement them.

Unleashing the Power of Artificial Intelligence (AI): Transforming Health Equity for All

Generative artificial intelligence (AI) experts led advocacy group leaders in a conversation about harnessing the power of AI. This report summarizes the suggestions for generative AI use, practical applications, and cautionary insights discussed during this Community of Practice.

AI Empowerment: Mastering the Art of Smart Prompting for Patient Advocacy

By enhancing our skills in communicating with AI we are expanding our capacity to understand and address the diverse needs of those we advocate for. This report summarizes strategies for patient advocacy groups to accelerate their impact through AI prompting.


We are proud of our relationships and interactions with patient advocacy groups, which are conducted according to the highest standards of integrity, with professionalism, and full respect for independence. Sanofi voluntarily discloses our annual payments to patient advocacy groups (PAGs).